Insider · CIK 0001699488

Karnani Vikram

Reports to the SEC for 3 companies · STOUGHTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001699488

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director, President and CEO	AAward	+79.3K sh	—	—	176,629
2026-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director, President and CEO	AAward	+32.5K sh	—	—	209,160
2026-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCF Tax Payment	Director, President and CEO	FTax Payment	−11.3K sh	$46.75	−$528K	197,864
2025-12-22	DYNDyne Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+59.7K sh	—	—	59,665
2025-11-12	COLLCOLLEGIUM PHARMACEUTICAL, INCF Tax Payment	Director, President and CEO	FTax Payment	−8,983 sh	$47.35	−$425K	96,989
2024-11-12	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director, President and CEO	AAward	+106K sh	—	—	105,972
2024-11-12	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)A Award	Director, President and CEO	AAward	+130K sh	—	—	130,344
2021-02-22	Horizon Therapeutics Public Ltd CoS Sale	EVP & President, International	SSale	−7,713 sh	$87.08	−$672K	104,810
2021-02-22	Horizon Therapeutics Public Ltd CoS Sale	EVP & President, International	SSale	−645 sh	$88.45	−$57.1K	104,165
2021-02-17	Horizon Therapeutics Public Ltd CoA Award	EVP & President, International	AAward	+1,965 sh	—	—	113,394
2021-02-17	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP & President, International	FTax Payment	−871 sh	$87.17	−$75.9K	112,523
2021-02-17	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award	EVP & President, International	AAward	+3,931 sh	—	—	3,931
2021-02-17	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award	EVP & President, International	AAward	+14.5K sh	—	—	14,512
2021-01-22	Horizon Therapeutics Public Ltd CoS Sale	EVP & President, International	SSale	−2,731 sh	$76.81	−$210K	111,429
2021-01-21	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP & President, International	MExercise/Conversion	+4,904 sh	—	—	116,333
2021-01-21	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP & President, International	FTax Payment	−2,173 sh	$77.43	−$168K	114,160
2021-01-21	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)M Exercise/Conversion	EVP & President, International	MExercise/Conversion	−4,904 sh	—	—	4,905
2021-01-06	Horizon Therapeutics Public Ltd CoS Sale	EVP & President, International	SSale	−30K sh	$75.00	−$2.25M	111,429
2021-01-05	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP & President, International	MExercise/Conversion	+47.3K sh	—	—	126,278
2021-01-05	Horizon Therapeutics Public Ltd CoA Award	EVP & President, International	AAward	+65.1K sh	—	—	191,366
2021-01-05	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP & President, International	FTax Payment	−49.9K sh	$73.28	−$3.66M	141,460
2021-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP & President, International	MExercise/Conversion	−18K sh	—	—	17,983
2021-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP & President, International	MExercise/Conversion	−17.3K sh	—	—	0
2021-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP & President, International	MExercise/Conversion	−12.1K sh	—	—	24,190
2021-01-04	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)A Award	EVP & President, International	AAward	+21K sh	—	—	20,957
2020-08-03	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP & President, International	MExercise/Conversion	+25.6K sh	$9.23	+$236K	67,769
2020-08-03	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP & President, International	MExercise/Conversion	+11.2K sh	$22.14	+$247K	78,941
2020-08-03	Horizon Therapeutics Public Ltd CoStock Option (Right to buy)M Exercise/Conversion	EVP & President, International	MExercise/Conversion	−25.6K sh	—	—	0
2020-08-03	Horizon Therapeutics Public Ltd CoStock Option (Right to buy)M Exercise/Conversion	EVP & President, International	MExercise/Conversion	−11.2K sh	—	—	72,828
2020-06-01	Horizon Therapeutics Public Ltd CoS Sale	EVP & President, International	SSale	−2,369 sh	$50.23	−$119K	42,169
2020-04-29	Horizon Therapeutics Public Ltd CoS Sale	EVP & President, International	SSale	−15.7K sh	$35.00	−$549K	43,489
2020-04-28	Horizon Therapeutics Public Ltd CoS Sale	EVP & President, International	SSale	−30.1K sh	$35.01	−$1.05M	59,172
2020-02-19	Horizon Therapeutics Public Ltd CoA Award	EVP & President, International	AAward	+15K sh	—	—	95,884
2020-02-19	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP & President, International	FTax Payment	−6,649 sh	$36.06	−$240K	89,235
2020-02-19	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award	EVP & President, International	AAward	+30K sh	—	—	30,014
2020-01-21	Horizon Therapeutics Public Ltd CoA Award	EVP & President, International	AAward	+5,353 sh	—	—	83,499
2020-01-21	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP & President, International	FTax Payment	−2,372 sh	$38.25	−$90.7K	81,127
2020-01-21	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award	EVP & President, International	AAward	+10.7K sh	—	—	10,708
2020-01-21	Horizon Therapeutics Public Ltd CoA Award	EVP & President, International	AAward	+4,904 sh	—	—	83,050
2020-01-21	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP & President, International	FTax Payment	−2,173 sh	$38.25	−$83.1K	80,877
2020-01-21	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award	EVP & President, International	AAward	+9,809 sh	—	—	9,809
2020-01-06	Horizon Therapeutics Public Ltd CoS Sale	EVP & President, International	SSale	−9,297 sh	$35.62	−$331K	78,146
2020-01-05	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP & President, International	MExercise/Conversion	+35.2K sh	—	—	92,654
2020-01-05	Horizon Therapeutics Public Ltd CoA Award	EVP & President, International	AAward	+19K sh	—	—	111,668
2020-01-05	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP & President, International	FTax Payment	−24.2K sh	$36.10	−$875K	87,443
2020-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP & President, International	MExercise/Conversion	−18K sh	—	—	35,966
2020-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP & President, International	MExercise/Conversion	−17.3K sh	—	—	17,260
2020-01-03	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)A Award	EVP & President, International	AAward	+36.3K sh	—	—	36,284
2019-07-01	Horizon Therapeutics Public Ltd CoS Sale	EVP & President, International	SSale	−13.1K sh	$25.02	−$328K	57,412
2019-03-23	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP & President, International	MExercise/Conversion	+9,500 sh	—	—	72,363

Recent filings

Accepted (ET)
Feb 124
Karnani Vikram0001699488-26-000002
SEC(opens sec.gov)
Dec 234
Karnani Vikram0001193125-25-330863
SEC(opens sec.gov)
Nov 144
Karnani Vikram0001699488-25-000004
SEC(opens sec.gov)
Nov 144
Karnani Vikram0001062993-24-019165
SEC(opens sec.gov)
Feb 234
Karnani Vikram0001209191-21-013382
SEC(opens sec.gov)
Feb 194
Karnani Vikram0001209191-21-012413
SEC(opens sec.gov)
Jan 224
Karnani Vikram0001209191-21-004998
SEC(opens sec.gov)
Jan 84
Karnani Vikram0001209191-21-002786
SEC(opens sec.gov)
Jan 64
Karnani Vikram0001209191-21-002414
SEC(opens sec.gov)

Companies

Address

C/O COLLEGIUM PHARMACEUTICAL, INC. 100 TECHNOLOGY CENTER DRIVE

STOUGHTON, MA, 02072